David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$345M |
| 2 |
Biogen
BIIB
|
+$281M |
| 3 |
Bausch Health
BHC
|
+$244M |
| 4 |
SPDR Gold Trust
GLD
|
+$238M |
| 5 |
Coca-Cola
KO
|
+$206M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$397M |
| 2 |
AGN
Allergan Inc
AGN
|
+$374M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$347M |
| 4 |
Microsoft
MSFT
|
+$265M |
| 5 |
IBM
IBM
|
+$251M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 10.34% |
| 2 | Technology | 9.79% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.68% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
CALL
Paychex
PAYX
$44.4B
| $3.04M | ﹤0.01% |
61,200
-72,000
| -54% | -$3.5M |
|
1702
Geron
GERN
$983M
| $3.03M | ﹤0.01% |
803,744
+785,072
| +4,205% | +$2.67M |
|
|
GES
1703
DELISTED
Guess Inc
GES
| $3.03M | ﹤0.01% |
162,749
+46,124
| +40% | +$870K |
|
1704
CALL
Allstate
ALL
$66.2B
| $3.02M | ﹤0.01% |
42,500
-53,900
| -56% | -$3.81M |
|
1705
PUT
Edwards Lifesciences
EW
$52.3B
| $3.02M | ﹤0.01% |
127,200
-4,200
| -3% | -$94.2K |
|
1706
CALL
Ulta Beauty
ULTA
$23.4B
| $3.02M | ﹤0.01% |
20,000
-79,900
| -80% | -$11.1M |
|
1707
Hilltop Holdings
HTH
$2.21B
| $3.02M | ﹤0.01% |
+155,103
| New | +$2.95M |
|
|
VRN
1708
DELISTED
Veren
VRN
| $3.01M | ﹤0.01% |
139,084
-543,775
| -80% | -$12.4M |
|
1709
Primerica
PRI
$9.27B
| $3M | ﹤0.01% |
59,039
-6,846
| -10% | -$356K |
|
1710
CALL
Boston Beer
SAM
$1.91B
| $3M | ﹤0.01% |
11,200
-8,800
| -44% | -$2.55M |
|
|
TFCFA
1711
CALL
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $2.99M | ﹤0.01% |
88,400
-35,800
| -29% | -$1.24M |
|
1712
Enpro
NPO
$6.54B
| $2.98M | ﹤0.01% |
+45,251
| New | +$2.9M |
|
|
CRAY
1713
DELISTED
Cray, Inc.
CRAY
| $2.98M | ﹤0.01% |
106,065
+99,615
| +1,544% | +$3.16M |
|
1714
Celldex Therapeutics
CLDX
$3.19B
| $2.98M | ﹤0.01% |
7,117
-3,395
| -32% | -$1.21M |
|
1715
PUT
Goodyear
GT
$1.8B
| $2.97M | ﹤0.01% |
109,700
-178,600
| -62% | -$4.67M |
|
1716
PUT
Huntington Ingalls Industries
HII
$11.7B
| $2.97M | ﹤0.01% |
+21,200
| New | +$2.73M |
|
1717
Yelp
YELP
$1.23B
| $2.97M | ﹤0.01% |
62,729
+40,527
| +183% | +$2.01M |
|
1718
Take-Two Interactive
TTWO
$43.7B
| $2.97M | ﹤0.01% |
116,612
+101,569
| +675% | +$2.77M |
|
1719
General Mills
GIS
$21.4B
| $2.96M | ﹤0.01% |
52,311
-20,441
| -28% | -$1.09M |
|
1720
NMI Holdings
NMIH
$3.4B
| $2.96M | ﹤0.01% |
395,272
-35,693
| -8% | -$279K |
|
|
DVAX
1721
DELISTED
Dynavax Technologies
DVAX
| $2.96M | ﹤0.01% |
131,919
-120,916
| -48% | -$2.32M |
|
1722
PUT
Hasbro
HAS
$13.6B
| $2.95M | ﹤0.01% |
46,700
-64,600
| -58% | -$3.79M |
|
|
SGY
1723
DELISTED
Stone Energy
SGY
| $2.95M | ﹤0.01% |
3,539
+1,624
| +85% | +$1.44M |
|
|
AWAY
1724
DELISTED
HOMEAWAY INC COM
AWAY
| $2.95M | ﹤0.01% |
97,680
+13,625
| +16% | +$394K |
|
1725
PUT
Kinder Morgan
KMI
$71.3B
| $2.94M | ﹤0.01% |
70,000
-189,000
| -73% | -$7.83M |
|
Similar funds
David Shaw's Q1 2015 Portfolio in Review
As of Q1 2015, David Shaw held 4,408 positions worth $65.3B, down 16% from $77.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15B in Q1 2015, closing 828 positions and reducing 1,784 holdings. Its most notable exit was Allergan Inc, an estimated $374M position sold in full.
By sector, the portfolio is most concentrated in Energy at 10% of assets, up from 8.6% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in SPDR Gold Trust worth $231M.
- David Shaw's largest Q1 2015 buy was SPDR Gold Trust: 2,033,000 shares worth $231M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q1 2015, an estimated $345M increase.
- David Shaw's biggest Q1 2015 reduction was LyondellBasell Industries, cutting an estimated $397M.
- David Shaw fully exited Allergan Inc in Q1 2015, selling an estimated $374M.
- David Shaw's ten largest holdings make up 11% of its $65.3B portfolio in Q1 2015.
- David Shaw opened 448 new positions and closed 828 in Q1 2015.
- David Shaw's portfolio value fell 16% quarter-over-quarter to $65.3B.
Based on D.E. Shaw & Co's 13F filing for Q1 2015, filed 15 May 2015.